Strides Pharma Science Ltd.
BSE: 532531 | Sector: Health care |
NSE: STAR | ISIN Code: INE939A01011 |
BSE 00:00 | 01 Feb | 284.35 |
-11.00 (-3.72%) |
OPEN
297.40 |
HIGH
303.85 |
LOW
281.45 |
NSE 00:00 | 01 Feb | 284.55 |
-11.00 (-3.72%) |
OPEN
297.95 |
HIGH
303.85 |
LOW
281.00 |
OPEN | 297.40 |
PREVIOUS CLOSE | 295.35 |
VOLUME | 31042 |
52-Week high | 413.50 |
52-Week low | 263.45 |
P/E | 17.99 |
Mkt Cap.(Rs cr) | 2,568 |
Buy Price | 0.00 |
Buy Qty | 0.00 |
Sell Price | 0.00 |
Sell Qty | 0.00 |
Strides Pharma Science Ltd. (STAR) - Net Profit
Net Profit
COMPANY | LATEST(Rs) | CHG | CHG(%) | Net Profit (Rs crore) |
Cipla | 1032.30 | 15.30 | 1.50 | 2957.93 |
Divi's Lab. | 3355.85 | 38.40 | 1.16 | 2948.54 |
Glenmark Pharma. | 382.65 | -1.60 | -0.42 | 1997.79 |
Glaxosmi. Pharma | 1250.75 | 4.05 | 0.32 | 1690.53 |
Dr Reddy's Labs | 4350.50 | 26.50 | 0.61 | 1623.20 |
Alkem Lab | 3033.10 | 23.35 | 0.78 | 1541.25 |
Aurobindo Pharma | 412.55 | 4.25 | 1.04 | 1454.71 |
Gland Pharma | 1263.05 | -37.15 | -2.86 | 1212.16 |
Torrent Pharma. | 1533.70 | 12.25 | 0.81 | 991.45 |
Sanofi India | 5442.55 | -53.40 | -0.97 | 944.40 |
Ipca Labs. | 853.55 | 3.40 | 0.40 | 870.94 |
Zydus Lifesci. | 435.60 | 4.85 | 1.13 | 857.90 |
Abbott India | 20698.40 | -144.00 | -0.69 | 798.70 |
Laurus Labs | 334.55 | 4.15 | 1.26 | 750.09 |
Ajanta Pharma | 1184.10 | -24.30 | -2.01 | 719.86 |
Apollo Hospitals | 4268.10 | 12.55 | 0.29 | 665.20 |
Pfizer | 3810.95 | -60.90 | -1.57 | 612.56 |
Suven Pharma | 491.80 | -0.70 | -0.14 | 558.10 |
Alembic Pharma | 540.00 | 1.90 | 0.35 | 543.55 |
Glenmark Life | 379.90 | -6.75 | -1.75 | 418.72 |
Quick Links for Strides Pharma Science:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices